文献速递心力衰竭与心肌病血脂与心血管预防

增加脂肪酸氧化通过调控Parkin介导的线粒体自噬预防高脂饮食诱导的心肌病

Increasing Fatty Acid Oxidation Prevents High-Fat Diet-Induced Cardiomyopathy Through Regulating Parkin-Mediated Mitophagy.
PubMed 文献 · Circulation · 2020-06-29

本研究在高脂饮食诱导的肥胖小鼠模型中,通过心脏特异性敲除ACC2增加脂肪酸氧化,发现尽管肥胖表型相似,但可预防高脂饮食引起的心功能障碍、病理重构和线粒体功能障碍,机制部分通过维持Parkin介导的线粒体自噬实现。

要点

  • 增加心脏脂肪酸氧化不引起心脏功能障碍,反而预防肥胖诱导的心肌病。
  • 有益效应部分通过调控Parkin介导的线粒体自噬维持线粒体功能。
  • 靶向Parkin依赖性线粒体自噬可能成为肥胖性心肌病的治疗策略。

核心结论

  • 增加心脏脂肪酸氧化本身不导致心脏功能障碍,但可预防慢性肥胖小鼠的心肌病。
  • 增强心脏脂肪酸氧化的有益效应部分通过调控Parkin介导的线粒体自噬维持线粒体功能。

研究设计与样本

  • 研究采用成年小鼠心脏特异性敲除ACC2的他莫昔芬诱导模型(ACC2 iKO),对照和ACC2 iKO小鼠接受高脂饮食喂养24周以诱导肥胖,检测心脏功能、线粒体功能和线粒体自噬活性。

主要发现

  • 尽管对照和ACC2 iKO小鼠均表现出相似的肥胖表型,但增加脂肪酸氧化可预防高脂饮食诱导的心脏功能障碍、病理重构和线粒体功能障碍。
  • 在体外,敲低ACC2增加脂肪酸氧化可预防棕榈酸酯诱导的线粒体功能障碍和心肌细胞死亡。
  • 高脂饮食抑制线粒体自噬活性并导致受损线粒体在心脏中积累,ACC2 iKO部分减轻此效应。
  • 机制上,ACC2 iKO预防高脂饮食诱导的Parkin下调;在对照高脂饮食小鼠心脏中,线粒体定位的Parkin严重减少,而ACC2 iKO高脂饮食小鼠部分恢复。

临床怎么用

  • 临床启示:增加心脏脂肪酸氧化可能不直接导致心脏毒性,而靶向Parkin依赖性线粒体自噬或成为肥胖性心肌病的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increased fatty acid oxidation (FAO) has long been considered a culprit in the development of obesity/diabetes mellitus-induced cardiomyopathy. However, enhancing cardiac FAO by removing the inhibitory mechanism of long-chain fatty acid transport into mitochondria via deletion of acetyl coenzyme A carboxylase 2 (ACC2) does not cause cardiomyopathy in nonobese mice, suggesting that high FAO is distinct from cardiac lipotoxicity. We hypothesize that cardiac pathology-associated obesity is attributable to the imbalance of fatty acid supply and oxidation. Thus, we here seek to determine whether further increasing FAO by inducing ACC2 deletion prevents obesity-induced cardiomyopathy, and if so, to elucidate the underlying mechanisms. METHODS: We induced high FAO in adult mouse hearts by cardiac-specific deletion of ACC2 using a tamoxifen-inducible model (ACC2 iKO). Control and ACC2 iKO mice were subjected to high-fat diet (HFD) feeding for 24 weeks to induce obesity. Cardiac function, mitochondria function, and mitophagy activity were examined. RESULTS: Despite both control and ACC2 iKO mice exhibiting a similar obese phenotype, increasing FAO oxidation by deletion of ACC2 prevented HFD-induced cardiac dysfunction, pathological remodeling, and mitochondria dysfunction, as well. Similarly, increasing FAO by knockdown of ACC2 prevented palmitate-induced mitochondria dysfunction and cardiomyocyte death in vitro. Furthermore, HFD suppressed mitophagy activity and caused damaged mitochondria to accumulate in the heart, which was attenuated, in part, in the ACC2 iKO heart. Mechanistically, ACC2 iKO prevented HFD-induced downregulation of parkin. During stimulation for mitophagy, mitochondria-localized parkin was severely reduced in control HFD-fed mouse heart, which was restored, in part, in ACC2 iKO HFD-fed mice. CONCLUSIONS: These data show that increasing cardiac FAO alone does not cause cardiac dysfunction, but protects against cardiomyopathy in chronically obese mice. The beneficial effect of enhancing cardiac FAO in HFD-induced obesity is mediated, in part, by the maintenance of mitochondria function through regulating parkin-mediated mitophagy. Our findings also suggest that targeting the parkin-dependent mitophagy pathway could be an effective strategy against the development of obesity-induced cardiomyopathy.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Shao D, Kolwicz SC, Wang P, et al. Increasing Fatty Acid Oxidation Prevents High-Fat Diet-Induced Cardiomyopathy Through Regulating Parkin-Mediated Mitophagy. Circulation. 2020. PMID: 32597196. doi:10.1161/CIRCULATIONAHA.119.043319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。